| Year |
Citation |
Score |
| 2019 |
Li F, Cain JD, Tombran-Tink J, Niyibizi C. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo. Journal of Bone and Mineral Metabolism. PMID 30607618 DOI: 10.1007/S00774-018-0982-4 |
0.406 |
|
| 2018 |
Li F, Cain JD, Tombran-Tink J, Niyibizi C. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling. Biochimica Et Biophysica Acta. PMID 30076958 DOI: 10.1016/J.Bbadis.2018.07.034 |
0.336 |
|
| 2016 |
Li F, Armstrong GB, Tombran-Tink J, Niyibizi C. Pigment epithelium derived factor upregulates expression of vascular endothelial growth factor by human mesenchymal stem cells: Possible role in PEDF regulated matrix mineralization. Biochemical and Biophysical Research Communications. PMID 27530920 DOI: 10.1016/J.Bbrc.2016.08.076 |
0.375 |
|
| 2015 |
Li F, Niyibizi C. Engraftability of Murine Bone Marrow-Derived Multipotent Mesenchymal Stem Cell Subpopulations in the Tissues of Developing Mice following Systemic Transplantation. Cells, Tissues, Organs. PMID 26447469 DOI: 10.1159/000438985 |
0.456 |
|
| 2015 |
Li F, Song N, Tombran-Tink J, Niyibizi C. Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization. Journal of Cellular Physiology. 230: 1243-9. PMID 25363869 DOI: 10.1002/Jcp.24859 |
0.43 |
|
| 2014 |
Song N, Armstrong AD, Li F, Ouyang H, Niyibizi C. Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering. Tissue Engineering. Part A. 20: 239-49. PMID 23865619 DOI: 10.1089/Ten.Tea.2013.0197 |
0.5 |
|
| 2013 |
Li F, Song N, Tombran-Tink J, Niyibizi C. Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells (Dayton, Ohio). 31: 2714-23. PMID 23939834 DOI: 10.1002/Stem.1505 |
0.375 |
|
| 2012 |
Li F, Niyibizi C. Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo. Bmc Cell Biology. 13: 35. PMID 23241430 DOI: 10.1186/1471-2121-13-35 |
0.434 |
|
| 2012 |
Li F, Whyte N, Niyibizi C. Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration. Biochemical and Biophysical Research Communications. 426: 475-9. PMID 22960177 DOI: 10.1016/J.Bbrc.2012.08.095 |
0.484 |
|
| 2012 |
Maddox JR, Ludlow KD, Li F, Niyibizi C. Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression. Cells, Tissues, Organs. 196: 107-16. PMID 22237379 DOI: 10.1159/000331332 |
0.696 |
|
| 2010 |
Li F, Wang X, Niyibizi C. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone. 47: 546-55. PMID 20570757 DOI: 10.1016/J.Bone.2010.05.040 |
0.429 |
|
| 2010 |
Li F, Bronson S, Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. Journal of Cellular Biochemistry. 109: 643-52. PMID 20039314 DOI: 10.1002/Jcb.22440 |
0.428 |
|
| 2009 |
Niyibizi C, Li F. Potential implications of cell therapy for osteogenesis imperfecta. International Journal of Clinical Rheumatology. 4: 57-66. PMID 20490372 DOI: 10.2217/17584272.4.1.57 |
0.397 |
|
| 2009 |
Maddox JR, Liao X, Li F, Niyibizi C. Effects of Culturing on the Stability of the Putative Murine Adipose Derived Stem Cells Markers. The Open Stem Cell Journal. 1: 54-61. PMID 19946473 DOI: 10.2174/1876893800901010054 |
0.696 |
|
| 2009 |
Mi MY, Tang Y, Salay MN, Li G, Huard J, Fu FH, Niyibizi C, Wang B. AAV Based Ex Vivo Gene Therapy in Rabbit Adipose-derived Mesenchymal Stem/Progenitor Cells for Osteogenesis The Open Stem Cell Journal. 1. DOI: 10.2174/1876893800901010069 |
0.477 |
|
| 2008 |
Gilbertson L, Ahn SH, Teng PN, Studer RK, Niyibizi C, Kang JD. The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells. The Spine Journal : Official Journal of the North American Spine Society. 8: 449-56. PMID 18455111 DOI: 10.1016/J.Spinee.2006.11.006 |
0.406 |
|
| 2008 |
Liao X, Li F, Wang X, Yanoso J, Niyibizi C. Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice. Stem Cells and Development. 17: 303-14. PMID 18447645 DOI: 10.1089/Scd.2007.0086 |
0.402 |
|
| 2007 |
Li F, Wang X, Niyibizi C. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells (Dayton, Ohio). 25: 3183-93. PMID 17823236 DOI: 10.1634/Stemcells.2007-0466 |
0.472 |
|
| 2007 |
Henderson JH, Welter JF, Mansour JM, Niyibizi C, Caplan AI, Dennis JE. Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Engineering. 13: 843-53. PMID 17394383 DOI: 10.1089/Ten.2006.0256 |
0.304 |
|
| 2006 |
Wang X, Li F, Niyibizi C. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases. Stem Cells (Dayton, Ohio). 24: 1869-78. PMID 16675597 DOI: 10.1634/Stemcells.2005-0430 |
0.418 |
|
| 2005 |
Jia F, Shimomura T, Niyibizi C, Woo SL. Downregulation of human type III collagen gene expression by antisense oligodeoxynucleotide. Tissue Engineering. 11: 1429-35. PMID 16259598 DOI: 10.1089/Ten.2005.11.1429 |
0.388 |
|
| 2005 |
Kawamura K, Chu CR, Sobajima S, Robbins PD, Fu FH, Izzo NJ, Niyibizi C. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Experimental Hematology. 33: 865-72. PMID 16038778 DOI: 10.1016/J.Exphem.2005.05.010 |
0.371 |
|
| 2005 |
Betz OB, Palmer GD, Betz VM, Crawford K, Niyibizi C, Vrahas MS, Evans CH. 889. Lanthanum Enhances Adenovirus-Mediated Gene Transfer Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.432 |
0.302 |
|
| 2004 |
Lattermann C, Baltzer AW, Zelle BA, Whalen JD, Niyibizi C, Robbins PD, Evans CH, Gruen GS. Feasibility of percutaneous gene transfer to an atrophic nonunion in a rabbit. Clinical Orthopaedics and Related Research. 237-43. PMID 15292814 DOI: 10.1097/00003086-200408000-00034 |
0.329 |
|
| 2004 |
Niyibizi C, Wang S, Mi Z, Robbins PD. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 955-63. PMID 15194062 DOI: 10.1016/J.Ymthe.2004.02.022 |
0.399 |
|
| 2004 |
Lattermann C, Zelle BA, Whalen JD, Baltzer AW, Robbins PD, Niyibizi C, Evans CH, Fu FH. Gene transfer to the tendon-bone insertion site. Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the Esska. 12: 510-5. PMID 15014945 DOI: 10.1007/S00167-003-0482-4 |
0.369 |
|
| 2004 |
Niyibizi C, Wang S, Mi Z, Robbins PD. Gene therapy approaches for osteogenesis imperfecta. Gene Therapy. 11: 408-16. PMID 14724682 DOI: 10.1038/Sj.Gt.3302199 |
0.327 |
|
| 2003 |
Shimomura T, Jia F, Niyibizi C, Woo SL. Antisense oligonucleotides reduce synthesis of procollagen alpha1 (V) chain in human patellar tendon fibroblasts: potential application in healing ligaments and tendons. Connective Tissue Research. 44: 167-72. PMID 14504037 DOI: 10.1080/03008200390215872 |
0.374 |
|
| 2003 |
Ahn S, Sobajima S, Teng P, Niyibizi C, Robins PD, Gilbertson LG, Kang JD. 9. The effects of adenovirus mediated delivery of BMP-12 cDNA on matrix synthesis in annulus fibrosus and nucleus pulposus cells from degenerated human discs The Spine Journal. 3: 70-71. DOI: 10.1016/S1529-9430(03)00189-X |
0.344 |
|
| 2002 |
Niyibizi C, Wallach CJ, Mi Z, Robbins PD. Approaches for skeletal gene therapy. Critical Reviews in Eukaryotic Gene Expression. 12: 163-73. PMID 12449341 DOI: 10.1615/Critreveukaryotgeneexpr.V12.I3.10 |
0.334 |
|
| 2001 |
Niyibizi C, Smith P, Mi Z, Phillips CL, Robbins P. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. Journal of Cellular Biochemistry. 83: 84-91. PMID 11500956 DOI: 10.1002/Jcb.1209 |
0.459 |
|
| 2001 |
Kim MK, Niyibizi C. Interaction of TGF-beta1 and rhBMP-2 on human bone marrow stromal cells cultured in collagen gel matrix. Yonsei Medical Journal. 42: 338-44. PMID 11456401 DOI: 10.3349/Ymj.2001.42.3.338 |
0.374 |
|
| 2001 |
Niyibizi C, Kavalkovich K, Yamaji T, Woo SL. Type V collagen is increased during rabbit medial collateral ligament healing. Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the Esska. 8: 281-5. PMID 11061296 DOI: 10.1007/S001670000134 |
0.358 |
|
| 2001 |
Niyibizi C, Kim M. Novel approaches to fracture healing. Expert Opinion On Investigational Drugs. 9: 1573-80. PMID 11060761 DOI: 10.1517/13543784.9.7.1573 |
0.324 |
|
| 2000 |
Shuler FD, Georgescu HI, Niyibizi C, Studer RK, Mi Z, Johnstone B, Robbins RD, Evans CH. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 18: 585-92. PMID 11052495 DOI: 10.1002/Jor.1100180411 |
0.33 |
|
| 2000 |
Lian JB, Niyibizi C. Gene therapy for genetic diseases of bone Clinical Orthopaedics and Related Research. PMID 11039765 DOI: 10.1097/00003086-200010001-00021 |
0.308 |
|
| 2000 |
Niyibizi C, Smith P, Mi Z, Robbins P, Evans C. Potential of gene therapy for treating osteogenesis imperfecta. Clinical Orthopaedics and Related Research. S126-33. PMID 11039761 DOI: 10.1097/00003086-200010001-00017 |
0.372 |
|
| 2000 |
Musgrave DS, Bosch P, Lee JY, Pelinkovic D, Ghivizzani SC, Whalen J, Niyibizi C, Huard J. Ex vivo gene therapy to produce bone using different cell types. Clinical Orthopaedics and Related Research. 290-305. PMID 10987005 DOI: 10.1097/00003086-200009000-00040 |
0.446 |
|
| 2000 |
Suzuki K, Oyama M, Faulcon L, Robbins PD, Niyibizi C. In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effect on the cells in vitro. Cell Transplantation. 9: 319-27. PMID 10972331 DOI: 10.1177/096368970000900303 |
0.451 |
|
| 2000 |
Goto H, Shuler FD, Niyibizi C, Fu FH, Robbins PD, Evans CH. Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta(1)gene. Osteoarthritis and Cartilage. 8: 266-71. PMID 10903880 DOI: 10.1053/Joca.1999.0300 |
0.427 |
|
| 2000 |
Smith P, Shuler FD, Georgescu HI, Ghivizzani SC, Johnstone B, Niyibizi C, Robbins PD, Evans CH. Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factor genes in the presence and absence of interleukin-1 Arthritis and Rheumatism. 43: 1156-1164. PMID 10817570 DOI: 10.1002/1529-0131(200005)43:5<1156::Aid-Anr26>3.0.Co;2-M |
0.349 |
|
| 2000 |
Sechriest VF, Miao YJ, Niyibizi C, Westerhausen-Larson A, Matthew HW, Evans CH, Fu FH, Suh JK. GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. Journal of Biomedical Materials Research. 49: 534-41. PMID 10602087 DOI: 10.1002/(Sici)1097-4636(20000315)49:4<534::Aid-Jbm12>3.0.Co;2-# |
0.364 |
|
| 2000 |
Watanabe N, Celechovsky C, Niyibizi C, Wang JH, Takai S, Woo SL. THE EFFECTS OF GROWTH FACTORS ON PROLIFERATION AND MATRIX SYNTHESIS OF FIBROBLASTS FROM GOAT MEDIAL COLLATERAL LIGAMENT Journal of Musculoskeletal Research. 4: 257-264. DOI: 10.1142/S0218957700000318 |
0.325 |
|
| 2000 |
Kasemkijwattana C, Menetrey J, Goto H, Niyibizi C, Fu FH, Huard J. The use of growth factors, gene therapy and tissue engineering to improve meniscal healing Materials Science and Engineering: C. 13: 19-28. DOI: 10.1016/S0928-4931(00)00172-7 |
0.342 |
|
| 1999 |
Oyama M, Tatlock A, Fukuta S, Kavalkovich K, Nishimura K, Johnstone B, Robbins PD, Evans CH, Niyibizi C. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Therapy. 6: 321-9. PMID 10435082 DOI: 10.1038/Sj.Gt.3300839 |
0.415 |
|
| 1999 |
Goto H, Shuler FD, Lamsam C, Moller HD, Niyibizi C, Fu FH, Robbins PD, Evans CH. Transfer of lacZ marker gene to the meniscus. The Journal of Bone and Joint Surgery. American Volume. 81: 918-25. PMID 10428122 DOI: 10.2106/00004623-199907000-00003 |
0.311 |
|
| 1998 |
Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD, Evans CH. Potential role for gene therapy in the enhancement of fracture healing. Clinical Orthopaedics and Related Research. S148-53. PMID 9917635 DOI: 10.1097/00003086-199810001-00016 |
0.362 |
|
| 1998 |
Fukuta S, Oyama M, Kavalkovich K, Fu FH, Niyibizi C. Identification of types II, IX and X collagens at the insertion site of the bovine achilles tendon. Matrix Biology : Journal of the International Society For Matrix Biology. 17: 65-73. PMID 9628253 DOI: 10.1016/S0945-053X(98)90125-1 |
0.361 |
|
| 1997 |
Balk ML, Bray J, Day C, Epperly M, Greenberger J, Evans CH, Niyibizi C. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim). Bone. 21: 7-15. PMID 9213002 DOI: 10.1016/S8756-3282(97)00075-6 |
0.47 |
|
| 1997 |
Marui T, Niyibizi C, Georgescu HI, Cao M, Kavalkovich KW, Levine RE, Woo SL. Effect of growth factors on matrix synthesis by ligament fibroblasts. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 15: 18-23. PMID 9066522 DOI: 10.1002/Jor.1100150104 |
0.322 |
|
| 1996 |
Niyibizi C, Visconti CS, Kavalkovich K, Woo SL. Collagens in an adult bovine medial collateral ligament: immunofluorescence localization by confocal microscopy reveals that type XIV collagen predominates at the ligament-bone junction. Matrix Biology : Journal of the International Society For Matrix Biology. 14: 743-51. PMID 8785589 DOI: 10.1016/S0945-053X(05)80017-4 |
0.374 |
|
| 1996 |
Niyibizi C, Sagarrigo Visconti C, Gibson G, Kavalkovich K. Identification and immunolocalization of type X collagen at the ligament-bone interface. Biochemical and Biophysical Research Communications. 222: 584-9. PMID 8670248 DOI: 10.1006/Bbrc.1996.0787 |
0.376 |
|
| 1996 |
Sagarriga Visconti C, Kavalkovich K, Wu J, Niyibizi C. Biochemical analysis of collagens at the ligament-bone interface reveals presence of cartilage-specific collagens. Archives of Biochemistry and Biophysics. 328: 135-42. PMID 8638922 DOI: 10.1006/Abbi.1996.0153 |
0.407 |
|
| 1996 |
Niyibizi C, Balk M, Bray J, Day C, Greenberger J, Epperly M, Evans C. Osteogenic potential of bone marrow stromal cells from oim mice Matrix Biology. 15: 189. DOI: 10.1016/S0945-053X(96)90087-6 |
0.386 |
|
| 1994 |
Niyibizi C, Eyre DR. Structural analysis of the extension peptides on matrix forms of type V collagen in fetal calf bone and skin. Biochimica Et Biophysica Acta. 1203: 304-9. PMID 8268215 DOI: 10.1016/0167-4838(93)90099-D |
0.323 |
|
| 1994 |
Niyibizi C, Chan R, Wu JJ, Eyre D. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. Biochemical and Biophysical Research Communications. 202: 328-33. PMID 8037728 DOI: 10.1006/Bbrc.1994.1931 |
0.329 |
|
| 1994 |
Niyibizi C, Eyre DR. Structural characteristics of cross-linking sites in type V collagen of bone. Chain specificities and heterotypic links to type I collagen. European Journal of Biochemistry. 224: 943-50. PMID 7925418 DOI: 10.1111/J.1432-1033.1994.00943.X |
0.315 |
|
| 1990 |
Niyibizi C, Eyre DR. Bone type V collagen: chain composition and location of a trypsin cleavage site. Connective Tissue Research. 20: 247-50. PMID 2612158 DOI: 10.3109/03008208909023894 |
0.31 |
|
| 1989 |
Niyibizi C, Eyre DR. Identification of the cartilage alpha 1(XI) chain in type V collagen from bovine bone. Febs Letters. 242: 314-8. PMID 2914614 DOI: 10.1016/0014-5793(89)80492-2 |
0.329 |
|
| 1988 |
Niyibizi C, Wu JJ, Eyre DR. The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue. Biochimica Et Biophysica Acta. 916: 493-9. PMID 3689806 DOI: 10.1016/0167-4838(87)90196-8 |
0.324 |
|
| 1985 |
REST M, NIYIBIZI C, FIETZEK PP. Human Placental ?1(V) ?2(V) ?3(V) and [?1(V)]2, ?2(V) Collagen Heterotrimers Annals of the New York Academy of Sciences. 460: 517-519. DOI: 10.1111/j.1749-6632.1985.tb51227.x |
0.533 |
|
| Show low-probability matches. |
